Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: Characterisation and comparison with other SGLT-2 inhibitors - Grempler, R; Thomas, L; Eckhardt, M (Diabetes Obes Metab, 2012)
et al.